{"cveId": "CVE-2018-14787", "cwe": ["CWE-269", "CWE-269", "CWE-269", "CWE-269"], "cvss": [{"baseScore": "7.8", "version": "3.1", "Attack Vector": "Low", "Attack Complexity": "Low", "Privileges Required": "Low", "User Interaction": "None", "Scope": "Unchaged", "Confidentiality Impact": "High", "Integrity Impact": "High", "Availability Impact": "High"}], "references": ["https://www.usa.philips.com/healthcare/about/customer-support/product-security", "https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01"], "description": ["In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions."], "published": "2018-08-22T18:29:00.340", "state": "PUBLIC", "vendorName": ["Philips"], "productName": ["IntelliSpace Cardiovascular (ISCV) products"], "github": {"advisories": [], "commits": [], "pocAdvisorie": null, "repo": null, "info": {}}, "pocList": []}